Skip to main content
Clinical Trials/NCT01611389
NCT01611389UnknownNot Applicable

Minimizing Right Ventricular Pacing in Dual-chamber Pacemaker Patients With Sinus Node Disease and First Degree Atrioventricular Block.

Military Institute od Medicine National Research Institute2 sites in 1 country60 target enrollmentStarted: September 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Oxygen uptake (cardiopulmonary exercise testing).

Study Overview

Brief Summary

The aim of this study is to evaluate the effect of minimizing right ventricular pacing in dual-chamber pacemaker patients with sinus node disease (SND) and first degree atrioventricular block (AVIB)on exercise capacity, quality of life and other heart failure measures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • prolonged PQ interval > 200 ms,
  • percentage of right ventricular pacing with standard AV delay > 90.

Exclusion Criteria

  • second or third degree atrioventricular block,
  • permanent atrial fibrillation.

Outcomes

Primary Outcomes

Oxygen uptake (cardiopulmonary exercise testing).

Time Frame: 3 months

Secondary Outcomes

  • Left ventricular ejection fraction.(3 months)
  • Quality of life(3 months)
  • Arrhythmia(3 months)
  • Ventilatory anaerobic threshold (cardiopulmonary exercise testing)(3 months)
  • VE/VCO2 slope (cardiopulmonary exercise testing).(3 months)

Investigators

Sponsor
Military Institute od Medicine National Research Institute
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Minimizing Ventricular Pacing | Clinical Trial